View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Sponsored by

Future Unicorns in Artificial Intelligence​

Free White Paper

Future Unicorns in Artificial Intelligence​

Future Unicorns in Artificial Intelligence​

Enter your details to receive the free paper:

Artificial intelligence (AI) startups are ushering in a new era of technology driven by innovations and grabbing the attention of investors worldwide. Whether to automate tasks or assist financial institutions in fraud detection and prevention or provide new generation medical and biotech solutions, startups are harnessing the disruptive power of AI to seize opportunities in all the sectors.

GlobalData’s Potential Unicorns list offers early predictive intelligence and enables to spot tomorrow’s winners today. The model identifies venture funded companies which have the potential to become unicorns (a valuation of at least $1 billion) driven by GlobalData’s proprietary machine learning algorithm which decodes millions of interactions between key deal attributes.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena